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Clinical assessment of speech correlates well with lung function
during induced bronchoconstriction
Nicholas Tayler1, Christopher Grainge1,2, Kerry Gove1, Peter Howarth1,3 and Judith Holloway1
Clinical assessment of asthma often includes a crude assessment of speech, for example whether the patient can speak in full
sentences. To date, this statement, despite appearing in national asthma guidelines, has not been related to lung function testing in
asthma exacerbation. Seven asthmatics underwent a bronchial challenge and were then recorded reading a standardised text for
1 min. The recordings were played to 88 healthcare professionals who were asked to estimate FEV1% predicted. Health care
professionals' estimations showed moderate correlation to FEV1% predicted (rho = 0.61 Po0.01). There were no signiﬁcant
differences between professionals grouped by seniority or speciality. Speech can intuitively be estimated by health care
professionals with moderate accuracy. This gives an evidence basis for the assessment in speech in acute asthma and may provide
a new avenue for monitoring.
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INTRODUCTION
Asthma is a chronic inﬂammatory respiratory condition that is
characterised by bronchoconstriction leading to a multitude of
symptoms, including wheeze, cough and dyspnoea.1
Assessment and monitoring of asthma is multifaceted,
including symptom-based diaries,2 as well as objective
measurements of lung function and airway inﬂammation.
Clinicians may also evaluate the way the patient is speaking,
either consciously or subconsciously, as part of an assessment of
asthma severity.3
Speech assessment is not a formal technique; however,
statements recorded in patient’s notes such as ‘inability to
complete sentences in one breath’ are used with other measures
to triage patients into severity categories during acute asthma in
adults and children in current published guidelines.4,5 In addition,
asthma limiting speech has been used as an indicator of severity
in longitudinal questionnaire-based studies of asthma.6 To our
knowledge, it has not been determined whether subjective
assessment of changes in the quality of speech in patients with
asthma can be related to alterations in pulmonary function.
Hypothesis
Health care professionals are able to accurately estimate forced
expiratory volume in 1 s (FEV1) during experimentally induced
bronchoconstriction from speech samples recorded at the time of
bronchial challenge.
MATERIALS AND METHODS
Adult mild asthmatics atopic to house dust mite (Dermatopha-
goides pteronyssinus) taking short-acting β2-agonists as required as
their only asthma therapy (Global Initiative for Asthma step 1)
were recruited. All the participants gave written informed consent,
and the study was approved by the local research ethics
committee. The participants were excluded if they had any past
medical history of psychiatric issues such as anxiety or haemato-
logical anomalies such as anaemia, as these factors may have
inﬂuenced baseline speech quality.
Seven volunteers were recruited and underwent either a
methacholine or allergen (D. pternyssinus) challenge to a targeted
fall in FEV1 of 20% from baseline according to published
protocols.7,8 After each challenge dose, the participant read a
standardised text for 30 s into a digital recorder ﬁtted with an
external microphone set at 10 cm from the mouth (Olympus
DM450 Speech Recorder with Olympus ME34 Microphone, Tokyo,
Japan).
The patients also evaluated their symptoms on a 200-mm
horizontal visual analogue scale (VAS) from ‘no asthma symptoms’
to ‘worst possible asthma symptoms’ immediately after each
episode of speech had been recorded. One speech track from
each participant was then selected to display a range of lung
functions from 100% FEV1 predicted to 53% FEV1 predicted; the
quality of speech was not known before selection of the data ﬁles.
Predicted lung function was calculated using the European
Respiratory Society data.9
Recorded speech was played on standardised equipment to 88
individuals including laboratory scientists, clerical support staff,
nurses and physicians from a range of specialities including
respiratory medicine, family practice, allergy medicine and
paediatrics.
Before hearing the speech recordings, assessors were read a
standard introduction (see Supplementary Information S1) brieﬂy
explaining what FEV1 means and how speech samples were
collected. They then listened to the speech recordings and
estimated FEV1 on a 150-mm horizontal VAS-labelled ‘FEV1 100%
predicted’ to ‘FEV1 0% predicted’. The VAS used was a continuous
line with no incremental markings.
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RESULTS
Participants' symptoms measured by VAS strongly correlated with
lung function (rho= 0.86 P= 0.014).
Estimated FEV1 from listening to speech showed a moderate
correlation with measured FEV1 values (rho = 0.61, Po0.01). The
median absolute difference of assessor’s estimation compared
with measured FEV1 was 10.6% (interquartile range 4–21.3%). This
is shown in Figure 1.
There was no signiﬁcant correlation between the patient’s
FEV1% predicted and the median difference of FEV1 estimation
(P= 0.43).
No signiﬁcant difference was found in the ability to estimate
FEV1 from speech between assessors when grouped either by
clinical experience or specialisation (P= 0.39 and P= 0.29). This is
summarised in Table 1.
DISCUSSION
Health care professionals, regardless of clinical experience or
speciality, can estimate lung function with moderate accuracy on
the basis of recorded speech alone with a median error of 10.6%.
In addition, asking our volunteers to evaluate their symptoms
using a VAS also provided a reasonably accurate assessment of
FEV1. Assessment of speech is a reasonable part of a comprehen-
sive asthma evaluation, and it may be especially useful when lung
function testing is not possible or available, although caution
should be taken not to overestimate asthma severity, as seen in
the majority of our results. This may be due to a confounding
factor, as health care professionals were aware that the patients
were asthmatic, and thus may have subconsciously adjusted their
estimations towards worsening lung function.
There was no signiﬁcant correlation between FEV1 values and
absolute difference of estimation, indicating that the accuracy of
prediction is not affected by pulmonary function.
Although assessment of speech has been advocated in
internationally approved asthma guidelines for many years4,5
and has been used in long-term follow-up of asthma,10 the ability
of health care professionals to estimate lung function from quality
of speech has not previously been assessed. We demonstrate that
alterations in speech that occur with worsening asthma can be
detected and apparently intuitively quantiﬁed, as type and length
of training do not affect accuracy.
More precise determination of the changes being detected, for
example, wheeze and duration or frequency of breath sounds,
could open new avenues for non-invasive monitoring of asthma.
In addition, further work could include determining whether
categorised exacerbations of asthma (mild, moderate, severe, life
threatening) can be detected with suitable accuracy by speech
analysis. Repeating this study with a larger sample size of speech
tracks from asthmatics could improve results.
In the meantime, traditional assessment of asthma severity by
evaluation of speech has value and should continue to be
recorded.
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